Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Operations

v2.4.0.6
Consolidated Statements Of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended 122 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Consolidated Statements Of Operations [Abstract]        
Revenue $ 62     $ 5,089
Operating expenses:        
Research and development 24,388 18,937 15,844 203,035
General and administrative 5,710 4,971 5,480 69,207
Total operating expenses 30,098 23,908 21,324 272,242
Loss from operations (30,036) (23,908) (21,324) (267,153)
Interest income (expense), net 25 60 (13) 8,344
Other income (expense), net 4,358 5,166 (2,311) 7,213
Net loss (25,653) (18,682) (23,648) (251,596)
Dividend related to beneficial conversion feature of redeemable convertible preferred stock       (40,862)
Net loss attributable to common stockholders $ (25,653) $ (18,682) $ (23,648) $ (292,458)
Net loss per common share:        
Basic and diluted $ (0.56) $ (0.56) $ (1.21)  
Weighted average number of shares used in net loss per common share calculations:        
Basic and diluted 45,900 33,654 19,594